Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03429036 · ClinicalTrials.gov registry record

Biospecimen Procurement for Head and Neck Disorders

A clinical trial of Head and Neck Neoplasms and Laryngeal Disease, sponsored by National Cancer Institute (NCI).

Recruiting
Registry status
1,000
Enrollment target
9
Study locations

NCT03429036 is a study of Head and Neck Neoplasms and Laryngeal Disease that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 1,000 participants, above the 222-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (350% higher). The trial reports 9 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03429036, a study of Head and Neck Neoplasms and Laryngeal Disease, is actively recruiting participants, sponsored by National Cancer Institute (NCI).

RECRUITING
Registry status
1,000 participants
Enrollment target
9
Study locations

Study Summary

Background: Researchers want to learn more about head and neck disorders. Understanding these disorders could help them find better treatments. To do this, they are collecting tissue samples for research. Objective: To create a repository of tissue samples and data to better study conditions of the head and neck. Eligibility: People who had or will have tissue samples taken because of a head or neck disorder. They must be ages 3 and older and not pregnant to join Part 2. Design: Participants will be screened with a questionnaire, medical history, and physical exam. Part 1. Participants will give permission for any of their tissue samples leftover from private care or other research protocols to be used. If participants tissue did not contain normal tissue or if they have a condition that suggests a genetic issue, they will be invited to join Part 2. Part 2: Participants will have additional samples collected. These could be: * Blood: Blood is drawn through a needle in the arm. * Cheek swab or brushing: A cotton swab or small brush is rubbed inside the cheek. * Saliva: They rinse their mouth with water and spit into a tube or cup. * Skin biopsy: They are injected with a numbing drug. A biopsy tool removes a small piece of skin. * Mucosal biopsy: They are injected in the mouth with a numbing medication. A small piece of tissue from the inside of the cheek is removed. Participants samples will be used for future research, including genetic testing. ...

Conditions Studied

Head and Neck Neoplasms Laryngeal Disease Hearing Disorder Pharyngeal Neoplasm Oral Mucosal Disease

Study Locations (9)

Maryland

  • Johns Hopkins Hospital Broadway Baltimore - Baltimore
  • Johns Hopkins Hospital Bayview - Baltimore
  • Johns Hopkins Hospital Greenspring - Baltimore
  • Johns Hopkins Suburban Hospital - Bethesda
  • Johns Hopkins Otolaryngology Clinic - Bethesda
  • National Institutes of Health Clinical Center - Bethesda

District of Columbia

  • MedStar Georgetown University Hospital - Washington D.C.
  • Johns Hopkins Hospital Sibley Memorial Hospital - Washington D.C.
  • George Washington University Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-05-23
Est. Completion 2026-12-03

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03429036

The ClinicalTrials.gov registry entry for NCT03429036 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 222-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (350% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 0 interventions.

NCT03429036 reports 9 study locations spanning 2 distinct geographic areas - top geographies include Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT03429036 about?

NCT03429036 is a clinical study titled "Biospecimen Procurement for Head and Neck Disorders". Background: Researchers want to learn more about head and neck disorders. Understanding these disorders could help them find better treatments. To do this, they are collecting tissue samples for research. Objective: To create a repository of tissue samples and data to better study conditions of t...

What is the current status of trial NCT03429036?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-05-23. Estimated completion is 2026-12-03.

What conditions does trial NCT03429036 study?

This clinical trial studies the following conditions: Head and Neck Neoplasms, Laryngeal Disease, Hearing Disorder, Pharyngeal Neoplasm, Oral Mucosal Disease.

Who is sponsoring clinical trial NCT03429036?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03429036 being conducted?

This trial has 9 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Neoplasms

All registered trials for this condition

Laryngeal Disease

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.